Welcome to the Ana Aslan Hub! This community hub — built on top of and serving as a companion to the Wikipedia article — lets you discuss, collect, and organize everything related to Ana Aslan.
Ana Aslan, the Romanian biologist and physician specializing in gerontology, was
born on January 1, 1897, in Brăila, Kingdom of Romania. This marks the beginning
of the life of a prominent figure in gerontology.
Ana Aslan, originally named Anna Aslanyan, was born in Brăila, Romania, to Armenian parents. Even from a young age, she displayed a strong will and a deep compassion, traits that would shape her future dedication to medicine and the well-being of others.
World War I Medical Service
1915-1918
During World War I, while still a medical student, Ana Aslan volunteered as a nurse, providing crucial care to wounded soldiers on the front lines. This experience exposed her to the harsh realities of life and death, solidifying her commitment to medicine and instilling in her a deep sense of empathy for human suffering.
Medical Degree from the University of Bucharest
1922
Ana Aslan successfully completed her medical studies at the University of Bucharest, marking a significant milestone in her journey to becoming a physician. Her academic achievements laid the foundation for her future research and clinical practice in the field of gerontology.
Appointment as Professor at the Institute of Geriatrics in Bucharest
1949
Aslan's dedication to understanding aging and geriatric health led to a professorship at the Institute of Geriatrics in Bucharest, Romania. This opportunity allowed her to establish a strong research foundation and pursue novel treatments. She was instrumental in shaping the field of geriatrics in Romania.
Development of Gerovital H3
1952
Ana Aslan's most significant contribution was the development of Gerovital H3, a procaine-based drug. She argued it had anti-aging effects and was effective in treating various age-related conditions. Gerovital H3 became widely popular, attracting international attention and making Romania a destination for 'rejuvenation' tourism.
Establishment of the National Institute of Geriatrics and Gerontology
1959
Recognizing the growing importance of geriatrics, Ana Aslan founded the world's first National Institute of Geriatrics and Gerontology in Bucharest. This institute became a leading center for research and treatment of age-related diseases, attracting scientists and patients from around the globe.
Development of Aslavital
1974
Building upon her research with Gerovital H3, Aslan developed Aslavital, a similar drug aimed at preventing premature aging. This further solidified her reputation as a pioneer in anti-aging treatments and contributed to the expanding field of geriatric pharmacology.
Death in Bucharest, Romania
May 20, 1988
Ana Aslan passed away in Bucharest, Romania, at the age of 91. Her death marked the end of an era in geriatric medicine. However, her legacy continues to inspire researchers and clinicians dedicated to improving the lives of the elderly. Her contributions remain pivotal in understanding and addressing the challenges of aging.
Brief
Known For
Developing Gerovital H3, a procaine-based drug marketed as an anti-aging treatment.
Key Dates and Places
Born Date: 1 January 1897.
Born Place: Brăila, Romania.
Death Date: 20 May 1988.
Death Place: Bucharest, Romania.
Career
Past occupations: Biologist, Physician, Gerontologist.
Previous Place of Work: Parhon Institute of Endocrinology, Bucharest; Established the National Institute of Gerontology and Geriatrics (Romania's first) in 1952.
Achievements and Recognition
Awards: Order of Work (Romania); León Bernard Foundation Prize (1952); 'Cross of Merit' of the Order of Labor, awarded by France; 'Cavalier des Palmes Academiques' title; Honorary member of the Academy of Sciences of New York; Honorary member of the Union of Scientific Medical Societies.
Wikipedia Article
Welcome to the Ana Aslan Hub! This community hub — built on top of and serving as a companion to the Wikipedia article — lets you discuss, collect, and organize everything related to Ana Aslan.
Ana Aslan, the Romanian biologist and physician specializing in gerontology, was
born on January 1, 1897, in Brăila, Kingdom of Romania. This marks the beginning
of the life of a prominent figure in gerontology.
Ana Aslan, originally named Anna Aslanyan, was born in Brăila, Romania, to Armenian parents. Even from a young age, she displayed a strong will and a deep compassion, traits that would shape her future dedication to medicine and the well-being of others.
World War I Medical Service
1915-1918
During World War I, while still a medical student, Ana Aslan volunteered as a nurse, providing crucial care to wounded soldiers on the front lines. This experience exposed her to the harsh realities of life and death, solidifying her commitment to medicine and instilling in her a deep sense of empathy for human suffering.
Medical Degree from the University of Bucharest
1922
Ana Aslan successfully completed her medical studies at the University of Bucharest, marking a significant milestone in her journey to becoming a physician. Her academic achievements laid the foundation for her future research and clinical practice in the field of gerontology.
Appointment as Professor at the Institute of Geriatrics in Bucharest
1949
Aslan's dedication to understanding aging and geriatric health led to a professorship at the Institute of Geriatrics in Bucharest, Romania. This opportunity allowed her to establish a strong research foundation and pursue novel treatments. She was instrumental in shaping the field of geriatrics in Romania.
Development of Gerovital H3
1952
Ana Aslan's most significant contribution was the development of Gerovital H3, a procaine-based drug. She argued it had anti-aging effects and was effective in treating various age-related conditions. Gerovital H3 became widely popular, attracting international attention and making Romania a destination for 'rejuvenation' tourism.
Establishment of the National Institute of Geriatrics and Gerontology
1959
Recognizing the growing importance of geriatrics, Ana Aslan founded the world's first National Institute of Geriatrics and Gerontology in Bucharest. This institute became a leading center for research and treatment of age-related diseases, attracting scientists and patients from around the globe.
Development of Aslavital
1974
Building upon her research with Gerovital H3, Aslan developed Aslavital, a similar drug aimed at preventing premature aging. This further solidified her reputation as a pioneer in anti-aging treatments and contributed to the expanding field of geriatric pharmacology.
Death in Bucharest, Romania
May 20, 1988
Ana Aslan passed away in Bucharest, Romania, at the age of 91. Her death marked the end of an era in geriatric medicine. However, her legacy continues to inspire researchers and clinicians dedicated to improving the lives of the elderly. Her contributions remain pivotal in understanding and addressing the challenges of aging.
Brief
Known For
Developing Gerovital H3, a procaine-based drug marketed as an anti-aging treatment.
Key Dates and Places
Born Date: 1 January 1897.
Born Place: Brăila, Romania.
Death Date: 20 May 1988.
Death Place: Bucharest, Romania.
Career
Past occupations: Biologist, Physician, Gerontologist.
Previous Place of Work: Parhon Institute of Endocrinology, Bucharest; Established the National Institute of Gerontology and Geriatrics (Romania's first) in 1952.
Achievements and Recognition
Awards: Order of Work (Romania); León Bernard Foundation Prize (1952); 'Cross of Merit' of the Order of Labor, awarded by France; 'Cavalier des Palmes Academiques' title; Honorary member of the Academy of Sciences of New York; Honorary member of the Union of Scientific Medical Societies.
general
